NVS

#4331
Novartis AG
168.62
+2.01%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
168.56
169.40
Jahresspanne
97.71
168.02
Tagesänderung
+2.01%
Monatliche Änderung
+13.30%
6 month change
+33.51%
Jahresänderung
+55.52%
Vorheriger Schlusskurs
165.29
Open
169.29
Bid
Ask
Low
168.56
High
169.40
Volumen
1 471
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 75 K
  • Founded 1996
  • CEO Vasant Narasimhan
  • Website www.novartis.com
  • Headquarter Switzerland
  • FIGI BBG000LYF3S8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Novartis AG

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.

Nachrichten